- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 219.42M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.5B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.51B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $22.73M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $22.58M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $59M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $10.88M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $522.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $520.1M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.58B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.54B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $223.81M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $170.98M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.31B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.15B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 202.76M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $156.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $90.41M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.3B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.25B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $48.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | $24.92M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $72.06M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $321.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $596.72M |